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Background
Through 2009, private-sector spending on substance use
disorder (SUD) treatment services has been a small and
stable portion of commercial health-care spending (0.4%
in 2003 to 2009). This study examines growth in spending
for SUD treatment services extended through 2012 among
the privately insured, to assess changing patterns in light
of parity legislation, changes in the economy, and availabil-
ity of new treatments.
Materials and methods
Spending data for 2004–2012 were compiled from the
Truven Health MarketScan® commercial database, which
contains private insurance claims for large employers,
representing 66 million covered lives nationally. Per enrol-
lee, all health and SUD treatment utilization and spending
were calculated for all services, inpatient care, outpatient
care, and prescription drugs.
Results
Between 2004 and 2012, per capita spending on SUD
treatment services for the commercially insured
increased by 15.4 percent annually, compared to 4.4 per-
cent for all services, and 5.4 percent for mental health
services. After 2009, overall health spending growth
decreased from 5.2 percent to 3.1 percent annually,
while SUD spending rapidly escalated, more than dou-
bling (10.4% to 24.2% annually). This acceleration
occurred for inpatient and outpatient care.
Outpatient care, particularly for drug abuse services,
accounted for two-thirds of 2009–2012 spending
growth, increasing at 33.8 percent annually. Price-per-
outpatient visit grew at 2.3 percent prior to 2009, and
14 percent after. Outpatient visit utilization growth
tripled (from 5.1% to 16.6% annually). While prior to
2009, SUD treatment medications grew rapidly (from a
small base), spending growth slowed after 2009 (espe-
cially alcohol treatment medications), similar to that of
general health medications.
Conclusions
While a small part of all health spending, private-sector
SUD spending on nonprescription care has continued to
accelerate compared to spending on all health, particu-
larly for the outpatient sector, and particularly after
2009. While it is not clear the exact causes of this
increase, some potential factors occurring concurrently
include: implementation of parity laws at the Federal
level and in more states, and the economic downturn,
which may have affected use of SUD services differently
than general health services.
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